Keeping the biotechnology of antisense in context

[1] Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (23) : 5310 - 5317

[2] Formation of a G-tetrad and higher order structures correlates with biological activity of the ReIA (NF-kappa B p65) 'antisense' oligodeoxynucleotide [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (13) : 2648 - 2656

[3] DEAN NM, 1994, J BIOL CHEM, V269, P16416

[4] SINGLE-BASE DISCRIMINATION FOR RIBONUCLEASE H-DEPENDENT ANTISENSE EFFECTS WITHIN INTACT HUMAN LEUKEMIA-CELLS [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (06) : 954 - 961

[5] OPTIMIZATION OF ANTISENSE OLIGODEOXYNUCLEOTIDE STRUCTURE FOR TARGETING BCR-ABL MESSENGER-RNA [J]. BLOOD, 1995, 86 (02) : 744 - 754

[6] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES BIND TO BASIC FIBROBLAST GROWTH-FACTOR, INHIBIT ITS BINDING TO CELL-SURFACE RECEPTORS, AND REMOVE IT FROM LOW-AFFINITY BINDING-SITES OIL EXTRACELLULAR-MATRIX [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2620 - 2627

[7] Anti-tumor activity of C-raf antisense (vol 2, pg 668, 1996) [J]. NATURE MEDICINE, 1999, 5 (02) : 127 - 127

[8] MONIA BP, 1992, J BIOL CHEM, V267, P19954

[9] Neckers LM, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P147

[10] Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6523 - 6528

[1] Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (23) : 5310 - 5317

[2] Formation of a G-tetrad and higher order structures correlates with biological activity of the ReIA (NF-kappa B p65) 'antisense' oligodeoxynucleotide [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (13) : 2648 - 2656

[3] DEAN NM, 1994, J BIOL CHEM, V269, P16416

[4] SINGLE-BASE DISCRIMINATION FOR RIBONUCLEASE H-DEPENDENT ANTISENSE EFFECTS WITHIN INTACT HUMAN LEUKEMIA-CELLS [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (06) : 954 - 961

[5] OPTIMIZATION OF ANTISENSE OLIGODEOXYNUCLEOTIDE STRUCTURE FOR TARGETING BCR-ABL MESSENGER-RNA [J]. BLOOD, 1995, 86 (02) : 744 - 754

[6] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES BIND TO BASIC FIBROBLAST GROWTH-FACTOR, INHIBIT ITS BINDING TO CELL-SURFACE RECEPTORS, AND REMOVE IT FROM LOW-AFFINITY BINDING-SITES OIL EXTRACELLULAR-MATRIX [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2620 - 2627

[7] Anti-tumor activity of C-raf antisense (vol 2, pg 668, 1996) [J]. NATURE MEDICINE, 1999, 5 (02) : 127 - 127

[8] MONIA BP, 1992, J BIOL CHEM, V267, P19954

[9] Neckers LM, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P147

[10] Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6523 - 6528